Curtiss-Wright
CW
$502.32
+0.17%
Curtiss-Wright Corporation is a diversified engineered-products manufacturer serving commercial aerospace, defense, power generation, and general industrial end markets through three reportable segments — Naval & Power (its largest revenue contributor), Aerospace & Industrial, and Defense Electronics — with the bulk of sales generated in the United States, followed by the United Kingdom. The company occupies a distinctive niche as a supplier of highly engineered, mission-critical components — coolant pumps, control rod drive mechanisms, weapons handling systems, valves, and compact motors — that are typically sole-sourced or deeply embedded in multi-decade defense and nuclear programs, giving it a moat built on qualification barriers rather than scale. The current investor narrative has shifted sharply from a multi-year re-rating story to a debate over whether the stock's de-rating reflects a cyclical air pocket or structural deterioration: despite posting record quarterly revenue and expanding margins in Q2 2026, the shares have fallen roughly 38% from their 52-week high amid a broad defense-sector rotation and valuation compression, with sell-side commentary (including recent coverage of peer BWXT) increasingly focused on premium multiples and back-half earnings concentration across the naval nuclear supply chain. Attention now centers on whether Curtiss-Wright's naval defense and power & process franchises can sustain mid-single-digit organic growth against a backdrop of margin expansion and aggressive buyback activity that has reduced the diluted share count for several consecutive quarters.…
CW
Curtiss-Wright
$502.32
Related headlines
Investment Opinion: Should I buy CW Today?
Rating: Hold. The core thesis is that Curtiss-Wright is a high-quality, mission-critical defense and industrial franchise undergoing a severe valuation reset, but the technical downtrend and still-premium multiples argue for patience until a base forms. The analyst consensus is 'buy' with a mean rating of 1.78 and an average target of $714.00 (42.1% upside), but the wide target range ($622–$870) and reiterated Hold/Neutral ratings from Stifel and Citigroup suggest the sell-side is waiting for evidence of a fundamental inflection.
Supporting evidence includes 5.41% year-over-year revenue growth in Q2 2026, 39.40% gross margin (up from 37.21%), 19.34% operating margin (up from 17.83%), and 27.6% diluted EPS growth to $4.07. Free cash flow of $625.3M provides a 3.0% FCF yield, and the company has reduced diluted shares to 37.12M from 37.87M through buybacks. However, the trailing PE of 42.60x and EV/EBITDA of 27.37x remain premium multiples for an industrial with mid-single-digit growth, and the PEG of 1.94 suggests the growth is fully priced.
The biggest risks are a break below the $490.05 52-week low, which could trigger further momentum selling, and a deceleration in naval defense order flow that would undermine the premium multiple. This Hold would upgrade to Buy if the stock stabilizes above $550 with improving volume and the forward PE compresses below 25x, or if Q3 earnings show revenue growth accelerating above 7% with margin expansion. It would downgrade to Sell if revenue growth falls below 3% or if gross margins slip below 37%. On balance, the stock is fairly valued to slightly overvalued relative to its growth rate, but undervalued relative to analyst targets — a classic 'wait for the turn' situation.
Sign up to view all
CW 12-Month Price Forecast
Curtiss-Wright presents a classic tension between deteriorating price action and intact fundamentals. The stock's 29% three-month decline and position near its 52-week low reflect a stock-specific de-rating (beta 0.883) rather than market weakness, yet the company continues to post record revenue, expanding margins, and strong cash flow. The valuation has moved from stretched to merely full, but at 42.6x trailing PE and 27.4x EV/EBITDA, there is still room for compression if growth decelerates. I would upgrade to bullish if the stock stabilizes above $550 with improving volume and Q3 earnings show revenue growth above 7%, or downgrade to bearish if it breaks below $490 with accelerating selling.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Curtiss-Wright's 12-month outlook, with a consensus price target around $714.00 and implied upside of +42.1% versus the current price.
Average Target
$714.00
0 analysts
Implied Upside
+42.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$622 - $870
Analyst target range
Coverage is moderate, with 8 analysts publishing targets and a consensus recommendation of "buy" (mean rating of 1.78 on a 1-to-5 scale where lower is more bullish). The average target price of $714.00 implies 42.1% upside from the current $502.32, a spread that is unusually wide for a large-cap industrial and signals that the sell-side has not yet marked estimates to the recent price action. Consensus estimated revenue of $5.17 billion (range $5.11–$5.23 billion) and estimated EPS averaging $23.37 (range $23.04–$23.77) suggest analysts expect continued mid-single-digit top-line growth with stable margins, and the bullish consensus stands in stark contrast to the stock's -29.03% three-month performance.\n\nThe target range of $622.00 to $870.00 is exceptionally wide — a 39.9% spread between low and high — indicating genuine disagreement about the company's trajectory rather than a tightly clustered view. The high target of $870.00 implies roughly 73% upside and would require multiple expansion back toward the stock's 2025 peak valuation alongside sustained naval-defense order flow and margin expansion; the low target of $622.00 still implies 23.8% upside, meaning even the most cautious analyst sees the current price as oversold, which is a meaningful signal. Institutional ratings, however, show a pattern of caution rather than conviction: Stifel has reiterated Hold on every dated action from December 2025 through July 2026, Citigroup has maintained Neutral across five updates from January through July 2026, and only Morgan Stanley carries an Overweight (last affirmed November 2025) — a distribution that leans neutral-to-hold despite the "buy" consensus label. The combination of a bullish average target, a wide dispersion, and a stream of reiterated Hold/Neutral ratings suggests analysts are waiting for evidence of a fundamental inflection before upgrading, and the gap between the $714 average target and the $502 price is more a reflection of stale targets than fresh conviction.
Drowning in data?
Find the real signal!
Bulls vs Bears: CW Investment Factors
The bear case currently has stronger near-term evidence: the stock is in a pronounced downtrend, down 29% over three months and sitting just above its 52-week low, with premium valuation multiples (42.6x trailing PE, 27.4x EV/EBITDA) that still leave room for compression. However, the bull case is supported by tangible fundamental strength — 27.6% EPS growth, 39.4% gross margins, 19.1% ROE, and a diversified mission-critical franchise — that contrasts sharply with the price action. The single most important tension is whether the de-rating reflects a cyclical air pocket in defense spending or structural deterioration in the naval nuclear supply chain; resolution of this debate, likely via order flow and guidance, will determine whether the stock re-rates toward the $714 analyst target or breaks below $490.
Bullish
- Margin expansion despite modest growth: Q2 2026 gross margin rose to 39.40% from 37.21% a year earlier, and operating margin climbed to 19.34% from 17.83%, driving 27.6% diluted EPS growth to $4.07 versus 5.4% revenue growth. This demonstrates genuine operating leverage and mix benefit, not just volume-driven earnings.
- Analyst targets imply substantial upside: The average analyst target of $714.00 implies 42.1% upside from the current $502.32, and even the lowest target of $622.00 implies 23.8% upside. With 8 analysts and a consensus 'buy' rating (mean 1.78), the sell-side sees the current price as oversold.
- Diversified, mission-critical revenue base: Revenue is spread across Naval Defense ($263.1M), Aerospace Defense ($176.0M), Power & Process ($173.7M), Commercial Aerospace ($114.3M), General Industrial ($106.8M), and Ground Defense ($90.1M), limiting single-program concentration. These are sole-sourced, deeply embedded components with high qualification barriers.
- Strong cash generation and buyback support: Trailing free cash flow of $625.3M yields roughly 3.0% of the $20.6B market cap, and the company repurchased $14.7M in Q2 2026 after $139.8M in Q4 2025 and $290.0M in Q3 2025. Diluted shares fell to 37.12M from 37.87M a year earlier, boosting per-share metrics.
Bearish
- Severe downtrend and technical breakdown: The stock is down 29.03% over three months and 31.72% over six months, sitting just 1.5% above its 52-week low of $490.05 and 37.8% below its high of $808.16. It trades below every meaningful moving average, with a 36.87% max drawdown signaling a full-blown correction.
- Valuation still at a premium: Despite the drawdown, the trailing PE of 42.60x, forward PE of 29.28x, EV/EBITDA of 27.37x, and P/B of 8.14x remain premium multiples for an industrial. The PEG ratio of 1.94 indicates the growth embedded in the multiple is being paid for at a slight premium.
- Stale analyst targets mask caution: The $714 average target is likely stale given the stock's 29% three-month decline, and the target range of $622–$870 is exceptionally wide (39.9% spread). Stifel has reiterated Hold and Citigroup Neutral across multiple updates in 2026, suggesting analysts are waiting for a fundamental inflection.
- Modest growth leaves little room for error: Revenue grew only 5.41% year-over-year in Q2 2026, and consensus estimates $5.17B for the year. At 27.37x EV/EBITDA, any deceleration below mid-single digits could trigger further multiple compression, especially with back-half earnings concentration across the naval nuclear supply chain.
CW Technical Analysis
Curtiss-Wright is in a pronounced, sustained downtrend that has erased the prior year's gains: the stock is down 8.68% over the trailing twelve months and sits at $502.32, just 1.5% above its 52-week low of $490.05 and roughly 37.8% below its 52-week high of $808.16 — placing it at approximately 3.9% of its 52-week range. That positioning is the signature of a falling knife rather than a value opportunity in the making, with the price having surrendered the entire advance from the April–July 2026 run that peaked near $792.77 on July 6. The 36.87% maximum drawdown confirms a full-blown correction, and with the stock now trading below every meaningful moving-average reference in the visible price series, the path of least resistance remains lower until a base forms.\n\nShort-term momentum is decisively negative and accelerating on the downside: the 1-month change of -11.88% and 3-month change of -29.03% show the decline steepening rather than stabilizing, while the 6-month change of -31.72% and YTD change of -12.24% frame a two-stage breakdown — a July–September slide followed by a fresh leg lower in early October when the stock gapped from $553.35 on October 6 to $509.10 on October 7. Relative strength is uniformly poor, with the stock underperforming SPY by 13.10 percentage points over one month, 31.72 points over three months, and 39.20 points over six months, even as the S&P itself gained 15.53% over the past year. Volume of roughly 283,207 shares on the latest session is unremarkable, suggesting the selling has been persistent distribution rather than a single capitulation event — a pattern that typically requires a volume spike or positive catalyst to reverse.\n\nKey technical levels are now well defined: support rests at the 52-week low of $490.05, and a decisive break below that level would open the door to a deeper repricing with no visible historical floor in the provided series, likely triggering further momentum-driven selling. Resistance is layered — first at the $550–$570 shelf where the stock consolidated in mid-September, then at the $600 psychological zone, and ultimately the $808.16 52-week high, which is now a distant recovery target requiring a 60.9% advance. The beta of 0.883 indicates the stock is roughly 12% less volatile than the market, which is unusual for a name in this drawdown and implies the decline is driven by stock-specific de-rating rather than broad market beta — meaning position sizing should account for idiosyncratic risk, and any stabilization will likely require company-specific catalysts (earnings, guidance, or order flow) rather than a market tailwind.
Beta
0.88
0.88x market volatility
Max Drawdown
-36.9%
Largest decline past year
52-Week Range
$490-$808
Price range past year
Annual Return
-8.7%
Cumulative gain past year
| Period | CW Return | S&P 500 |
|---|---|---|
| 1m | -11.9% | +0.2% |
| 3m | -29.0% | +2.9% |
| 6m | -31.7% | +8.4% |
| 1y | -8.7% | +14.9% |
| ytd | -12.2% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CW Fundamental Analysis
The revenue trajectory remains solidly positive and, importantly, is accelerating at the margin: Q2 2026 revenue of $924.0 million grew 5.41% year-over-year versus $876.6 million in Q2 2025, and marked a sequential increase from Q1 2026's $913.7 million. The multi-quarter cadence shows consistent expansion — $805.6 million in Q1 2025, $876.6 million in Q2 2025, $869.2 million in Q3 2025, $947.0 million in Q4 2025, $913.7 million in Q1 2026, and $924.0 million in Q2 2026 — with the trailing four quarters totaling roughly $3.65 billion. Segment data shows Naval Defense as the largest contributor at $263.1 million, followed by Aerospace Defense at $176.0 million and Power & Process at $173.7 million, with Commercial Aerospace ($114.3 million), General Industrial ($106.8 million), and Ground Defense ($90.1 million) rounding out a well-diversified mix that limits single-program concentration risk.\n\nProfitability is robust and expanding: Q2 2026 net income reached $151.2 million on a 16.36% net margin, up from $121.1 million and a 13.81% margin in the year-ago quarter, while gross margin improved to 39.40% from 37.21% and operating margin rose to 19.34% from 17.83%. The sequential trend reinforces the point — gross margin climbed from 36.28% in Q1 2026 to 39.40% in Q2, and net margin from 14.03% to 16.36% — with the trailing twelve-month gross margin of 37.20% and operating margin of 18.24% consistent with a high-quality engineered-products franchise. Diluted EPS of $4.07 in Q2 2026 versus $3.19 a year earlier represents 27.6% growth, well ahead of the 5.4% revenue growth, confirming genuine operating leverage and mix benefit rather than purely volume-driven earnings.\n\nThe balance sheet and cash generation are healthy but not without blemishes: debt-to-equity of 0.519 and a current ratio of 1.436 indicate moderate leverage and adequate liquidity, while trailing free cash flow of $625.3 million against a $20.6 billion market cap implies a FCF yield of roughly 3.0%. Cash flow is seasonally lumpy — Q1 2026 operating cash flow was -$5.7 million (FCF -$17.5 million) before rebounding to $181.2 million in Q2 (FCF $151.7 million) — and the company returned capital aggressively, repurchasing $14.7 million of stock in Q2 2026 on top of $139.8 million in Q4 2025 and $290.0 million in Q3 2025, funded partly by drawing cash down from $371.3 million to $343.4 million. ROE of 19.11% and ROA of 8.49% are solid for an industrial, and interest coverage of roughly 18x (Q2 2026 operating income of $178.7 million versus $9.9 million interest expense) leaves ample cushion, though the low dividend yield of 0.17% and payout ratio of 7.2% confirm capital allocation is skewed toward buybacks over income.
Quarterly Revenue
$924008000.0B
2026-06
Revenue YoY Growth
+5.4%
YoY Comparison
Gross Margin
39.4%
Latest Quarter
Free Cash Flow
$625289000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CW Overvalued?
Because Curtiss-Wright is solidly profitable — Q2 2026 net income of $151.2 million and trailing EPS of $4.09 — the PE ratio is the appropriate primary metric, and it reveals a stock that is cheaper than it has been in years but still not statistically cheap: the trailing PE of 42.60x compares with a forward PE of 29.28x, a 31.3% compression that implies the market expects meaningful EPS growth over the next twelve months. That expectation is corroborated by consensus estimated EPS of $23.37, though the gap between the reported quarterly EPS run-rate and the annual estimate warrants scrutiny of how the estimate is constructed. The PEG ratio of 1.94 sits modestly above the 1.0 threshold, suggesting the growth embedded in the multiple is being paid for at a slight premium rather than a discount.\n\nRelative to its own history, the current multiple represents a dramatic re-rating: the trailing PE of 42.60x is well above the 28.53x recorded at Q4 2024 and the 17.74x at Q4 2023, and the price-to-sales ratio of 5.90x compares with 16.43x at Q4 2024 and 10.84x at Q4 2023 — though the historical series shows the stock traded at 30.29x sales as recently as Q2 2026, meaning the current 5.90x PS reflects a collapse in the multiple rather than a change in the underlying business. The price-to-book of 8.14x versus 5.53x at Q4 2024 and 3.66x at Q4 2023 confirms the stock spent 2025 and early 2026 priced for perfection, and the current de-rating is a normalization toward — but not yet below — historical norms. EV/EBITDA of 27.37x and EV/Sales of 5.25x remain premium multiples for an industrial, and the PCF ratio of 32.06x versus a historical 44.94x at Q4 2024 shows cash-flow-based valuation has compressed alongside earnings multiples.\n\nPeer comparison is constrained by the absence of a supplied industry-average multiple, but the internal evidence is instructive: a 42.60x trailing PE against a 29.28x forward PE, a 1.94 PEG, and an 8.14x P/B all point to a stock that still trades at a growth premium to the broader industrials and aerospace & defense complex despite its 37.8% drawdown from the 52-week high. The bull case for the premium rests on 39.4% gross margins, 19.3% operating margins, 19.1% ROE, and a naval-defense franchise with multi-year visibility; the bear case is that a 27.4x EV/EBITDA multiple leaves little room for error if the 5.4% revenue growth decelerates. On balance, the valuation has moved from clearly stretched to merely full, and the market is now pricing in execution rather than awarding a scarcity premium.
PE
42.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 15x~49x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the stock's premium valuation relative to its growth rate. At 42.60x trailing PE and 27.37x EV/EBITDA, the market is pricing in continued margin expansion and mid-single-digit growth; a deceleration below 5% or a margin reversal could trigger further multiple compression. Cash flow is seasonally lumpy — Q1 2026 operating cash flow was -$5.7M before rebounding to $181.2M in Q2 — and the company has been drawing down cash ($371.3M to $343.4M) to fund aggressive buybacks ($290.0M in Q3 2025 alone), which may limit financial flexibility if conditions tighten. Debt-to-equity of 0.519 is manageable, but interest coverage of 18x assumes stable operating income.
Market and competitive risks include the stock's idiosyncratic de-rating: despite a beta of 0.883, it has underperformed SPY by 31.72 percentage points over three months, indicating stock-specific selling pressure rather than broad market weakness. The defense sector is experiencing a rotation away from premium-multiple names, as evidenced by recent coverage of peer BWXT highlighting valuation and back-half earnings concentration across the naval nuclear supply chain. Regulatory and budgetary risks are inherent to defense suppliers, and any shift in U.S. naval procurement priorities or nuclear program funding could disproportionately impact Curtiss-Wright's largest segment (Naval Defense at $263.1M).
The worst-case scenario would be a break below the 52-week low of $490.05, which would open the door to a deeper repricing with no visible historical floor in the provided series. From the current $502.32, a decline to the 52-week low represents only -2.4%, but a move toward the analyst low target of $622.00 is actually upside; the true downside scenario would involve a sustained break below $490, potentially targeting the pre-2025 valuation range implied by the Q4 2024 PE of 28.53x applied to trailing EPS of $4.09, which would suggest a price near $116 — an extreme outcome. More realistically, a failure to stabilize at $490 could see the stock test $450–$470, representing a further -6% to -10% from current levels, with the 36.87% max drawdown already demonstrating the magnitude of prior corrections.
FAQ
The most severe risk is a technical breakdown below the $490.05 52-week low, which could trigger momentum-driven selling toward $450–$470. Second, valuation compression risk remains: at 42.60x trailing PE and 27.37x EV/EBITDA, any deceleration in revenue growth below 5% could cause further multiple contraction. Third, naval defense program funding or order delays could disproportionately impact the largest segment ($263.1M in Q2 revenue), and the stock's idiosyncratic de-rating (underperforming SPY by 31.72 percentage points over three months despite a beta of 0.883) suggests stock-specific selling pressure that may persist.
The 12-month forecast has three scenarios: a bull case (25% probability) targeting $714–$870 on defense-sector recovery and strong naval order flow; a base case (50% probability) targeting $550–$650 as the stock forms a base and gradually recovers; and a bear case (25% probability) targeting $450–$490 on a break below the 52-week low. The base case is most likely, assuming revenue growth of 4-6% and stable margins, with the stock recovering toward the lower end of the analyst target range as stale targets are revised.
CW trades at a trailing PE of 42.60x and a forward PE of 29.28x, with an EV/EBITDA of 27.37x and P/B of 8.14x. These are premium multiples for an industrial with 5.4% revenue growth, and the PEG of 1.94 suggests the growth is fully priced. However, relative to its own history, the stock has de-rated significantly from a Q4 2024 PE of 28.53x and a Q2 2026 PS of 30.29x, now trading at 5.90x sales. The market appears to be pricing in execution rather than awarding a scarcity premium, leaving the stock fairly valued to slightly overvalued relative to its growth rate but undervalued relative to analyst targets.
From a risk/reward perspective, CW offers 42.1% upside to the average analyst target of $714.00, but the stock is in a pronounced downtrend just 1.5% above its 52-week low of $490.05. The biggest downside risk is a break below $490, which could trigger further selling toward $450–$470. For long-term investors with a 2-3 year horizon, the current price may represent a reasonable entry point given the intact fundamentals (27.6% EPS growth, 39.4% gross margins), but waiting for a stabilization above $550 would reduce risk. Short-term traders should avoid catching the falling knife until a base forms.
CW is best suited for long-term investors with a 2-3 year horizon, given its mission-critical defense franchise, multi-decade program visibility, and strong cash generation. The low dividend yield of 0.17% and payout ratio of 7.2% mean income is not a reason to own it, but the aggressive buyback program (reducing diluted shares to 37.12M from 37.87M) supports per-share value. Short-term trading is risky given the 36.87% max drawdown and negative momentum, with the stock down 29.03% over three months. A minimum holding period of 18-24 months is suggested to ride out the current correction and benefit from any re-rating.
